Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Union Health ministry issues regulatory pathways for foreign-produced Covid-19 vaccines

Ruchika Sharma16 April 2021 4:44 PM IST

New Delhi: The Central government on Thursday issued the regulatory pathway in India for Covid-19 vaccines approved for restricted use by US FDA, EMA,...

Haffkine Institute secures Govt nod to manufacture Covaxin

Ruchika Sharma16 April 2021 3:42 PM IST

Mumbai: The Union government has given its permission to the city-based Haffkin Institute to manufacture Covaxin, an anti-coronavirus vaccine of...

First dose of AstraZeneca, Pfizer COVID-19 shots get equally strong antibody response from elderly

Ruchika Sharma16 April 2021 10:00 AM IST

London: The first study to directly compare immune reactions between Pfizer's and AstraZeneca's COVID-19 vaccines found strong and broadly similar...

West Pharma, Venus Remedies expand partnership to launch NovaGuard SA Pro Safety System in India

Ruchika Sharma16 April 2021 9:00 AM IST

Hyderabad: West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, recently announced...

Govt nod to boosting Remdesivir production to 78 lakh vials per month

Ruchika Sharma15 April 2021 3:05 PM IST

New Delhi: The government on Wednesday said it has given approval for stepping up the manufacturing capacity of remdesivir that would enhance the...

Delhi HC Restrains Use of CALDIMUST Trademark Deceptively Similar to Mankinds CALCIMUST

Mankind Pharma submits new drug application with CDSCO for anti diabetic molecule MKP10241

Ruchika Sharma15 April 2021 1:38 PM IST

New Delhi: Mankind Pharma, the 4th largest pharmaceutical company in India (As per IQVIA) has submitted its first Investigational New Drug (IND)...

India wants Pfizer, Moderna, JnJ to seek licence for covid vaccines soon: Govt official

Ruchika Sharma15 April 2021 1:16 PM IST

New Delhi: India wants Pfizer, Moderna and Johnson & Johnson to seek licence for their COVID-19 vaccines as soon as possible, a senior government...

Dr Reddys working on Sputnik V stability data on 2 to 8 C temperature range

Ruchika Sharma15 April 2021 12:48 PM IST

New Delhi: Dr Reddy's Laboratories is in the process of generating additional stability data for Russia's COVID-19 vaccine Sputnik V, which has a...

Sanofi to infuse Euro 400 million in new vaccine production site

Ruchika Sharma15 April 2021 12:33 PM IST

Paris: Sanofi has recently announced a EURO 400 million investment over five years to create a unique vaccine production center in Singapore, pushing...

16 applications cleared under PLI scheme for drug intermediates and APIs

Ruchika Sharma14 April 2021 5:17 PM IST

New Delhi: Ministry of Chemicals and Fertilizers has recently accorded approvals to 16 applicants under Production Linked Incentive (PLI) Scheme for...

Gilead Sciences cancer drug Trodelvy gets speedy USFDA approval

Ruchika Sharma14 April 2021 4:11 PM IST

Foster City: Drugmaker, Gilead Sciences, has recently announced that the U.S. Food and Drug Administration (USFDA) has granted accelerated...

Supply shortages delaying full-speed production of COVID-19 vaccine: Novavax

Ruchika Sharma14 April 2021 2:57 PM IST

New Delhi: Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok